MedDataX Logo

Evaluation of the Be Vape Free Curriculum of the Tobacco Prevention Toolkit

NCT ID: NCT05493982

Last Updated: 2025-12-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Clinical Phase

NA

Total Enrollment

10800 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-10-19

Study Completion Date

2026-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The Stanford Tobacco Prevention Toolkit is a free online curriculum developed for use by educators and health professionals in providing tobacco-specific prevention education to middle and high school students. A set of lessons focused on e-cigarette/vaping prevention education specifically is called the Be Vape Free curriculum. The aims of this study are to determine: (1) whether the Be Vape Free curriculum is effective in increasing middle and high school students' resistance to using tobacco and in decreasing positive attitudes towards and intentions to use e-cigarettes; (2) whether the Curriculum is effective in changing middle and high school students' actual use of tobacco; and (3) Examine heterogenous treatment effects identifying groups that benefit the most and those who do not benefit at all from the intervention.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

E-cigarette Use

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

youth tobacco education health prevention vaping e-cigarette

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Receives Stanford vaping prevention curriculum (pilot phase)

Stanford vaping prevention curriculum is administered as pilot arm preceding main experimental intervention.

Group Type EXPERIMENTAL

Stanford Vaping Prevention curriculum

Intervention Type BEHAVIORAL

Stanford vaping prevention curriculum delivered as a 5-session course administered in a school classroom setting.

Receives Stanford vaping prevention curriculum (randomized phase)

Stanford vaping prevention curriculum is administered.

Group Type EXPERIMENTAL

Stanford Vaping Prevention curriculum

Intervention Type BEHAVIORAL

Stanford vaping prevention curriculum delivered as a 5-session course administered in a school classroom setting.

Does not receive Stanford vaping prevention curriculum (randomized phase)

Receives another curriculum or no vaping prevention education.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Stanford Vaping Prevention curriculum

Stanford vaping prevention curriculum delivered as a 5-session course administered in a school classroom setting.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Middle school and high school students receiving health education at schools participating in the study

Exclusion Criteria

None
Minimum Eligible Age

10 Years

Maximum Eligible Age

20 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Cancer Institute (NCI)

NIH

Sponsor Role collaborator

Stanford University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Bonnie Halpern-Felsher

Marron and Mary Elizabeth Kendrick Professor in Pediatrics II

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bonnie Halpern-Felsher, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

Stanford University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Stanford University

Palo Alto, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1R01CA263121

Identifier Type: NIH

Identifier Source: secondary_id

View Link

61965

Identifier Type: -

Identifier Source: org_study_id